? Class 4 medicines defect information: Oxylan prolonged-release tablets, all strengths


G.L Pharma GmbH T/A Healthcare Pharma Ltd has informed the MHRA that the Patient Information Leaflet (PIL) within the packs for the specified batches is missing important safety-relevant text changes.


Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download [141.16 KB]


This circular is being shared under the Open Government Copywrite licence. Whilst we will publish alerts relevant to pharmacists, pharmacy technicians and pharmacy teams we recommend you also keep an eye on the SHOW website.




Published by

PIP editor

A pharmacist led training provider.

Leave a Reply

Your email address will not be published.